RecruitingNot ApplicableNCT06275126

Optimizing Surgical Decisions in Young Adults With Breast Cancer


Sponsor

Weill Medical College of Cornell University

Enrollment

800 participants

Start Date

Mar 13, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions. Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 44 Years

Inclusion Criteria3

  • Female aged 18-44
  • New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer
  • English or Spanish speaking

Exclusion Criteria3

  • Diagnosis of de novo Stage 4 breast cancer
  • Recurrent early-stage breast cancer
  • Bilateral breast cancer

Interventions

OTHERCONSYDER decision aid

Web-based breast cancer surgery decision aid


Locations(4)

Yale Cancer Center

New Haven, Connecticut, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

Weill Cornell Medicine

New York, New York, United States

Duke Cancer Institute

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06275126


Related Trials